The imaging and Cytometry facility is part of Généthon, which is a pharmaceutical organization specialized in understanding rare diseases and designing new approaches of therapy, mostly gene transfer The imaging and Cytometry facility offers services in imaging and cytometry, acquisition and analysis. The facility operates along the criteria fixed by the “Charte des Plates-Formes du Vivant” and retained for IBiSA labellisation. The facility organizes its activity around 3 main missions: services, training, Research and Development.
The facility interacts with different partners:
- inner departments of Genethon (5 R&D teams, vector production unit, technical development unit ; preclinical evaluation department)
- Genethon belongs itself to a public interest group named Genopole, which gathers Start-up, companies, facilities, institutes and public laboratories, and promote their activity and research. Consequently, the facility has strong interaction with Genopole partners.
The facility is open to any user outside Genopole, and is currently working with the CEA, the institute of myology, the “Institut de Recherche Biomédial des armées (IRBA)” etc.
Scope of activity: The facility concentrates on quantitative imaging of muscles and neuromuscular disease.